• Publications
  • Influence
Stanford Encyclopedia of Philosophy
Evolutionary psychology is one of many biologically informed approaches to the study of human behavior. Along with cognitive psychologists, evolutionary psychologists propose that much, if not all,Expand
  • 3,523
  • 82
  • PDF
Turing Machines
In 1 900 David Hilbert, the preeminent mathematician of his time, chal­ lenged the world of mathematics with a list of unsolved problems, pre­ sented in Paris before the International Congress of MExpand
  • 44
  • 4
  • PDF
The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: study protocol for a randomised controlled trial
BackgroundFor adults surviving stroke due to spontaneous (non-traumatic) intracerebral haemorrhage (ICH) who had taken an antithrombotic (i.e. anticoagulant or antiplatelet) drug for the preventionExpand
  • 15
  • 1
  • PDF
Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial
  • Martin Gillian John Catriona Maree Graeme J Allan Stephan Dennis Mead Forbes Graham Hackett Hankey House Lew, M. Dennis, +1,271 authors R. Hungwe
  • Medicine
  • Lancet (London, England)
  • 19 January 2019
Summary Background Results of small trials indicate that fluoxetine might improve functional outcomes after stroke. The FOCUS trial aimed to provide a precise estimate of these effects. Methods FOCUSExpand
  • 67
  • PDF
Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial
  • Rustam MS PAG CLM JM WN GD J DE N DJ PM Colin Daniel Fran Al-Shahi Salman Dennis Sandercock Sudlow Wardlaw W, R. Al-Shahi Salman, +932 authors K. Thomas
  • Medicine
  • Lancet (London, England)
  • 29 June 2019
Summary Background Antiplatelet therapy reduces the risk of major vascular events for people with occlusive vascular disease, although it might increase the risk of intracranial haemorrhage. PatientsExpand
  • 35
Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial
Summary Background Findings from the RESTART trial suggest that starting antiplatelet therapy might reduce the risk of recurrent symptomatic intracerebral haemorrhage compared with avoidingExpand
  • 28
  • PDF